spacer
spacer

PDBsum entry 2c1e

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
2c1e

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
147 a.a. *
103 a.a. *
Ligands
PHQ-ASP-GLU-VAL-
AA1
Waters ×414
* Residue conservation analysis
PDB id:
2c1e
Name: Hydrolase/hydrolase inhibitor
Title: Crystal structures of caspase-3 in complex with aza-peptide michael acceptor inhibitors.
Structure: Caspase-3 subunit p17. Chain: a. Fragment: alpha subunit, residues 29-175. Synonym: casp-3, apopain, cysteine protease cpp32, yama protein, cpp- 32, srebp cleavage activity 1, sca-1. Engineered: yes. Caspase-3 subunit p12. Chain: b. Fragment: beta subunit, residues 176-277.
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 469008. Synthetic: yes. Synthetic construct. Organism_taxid: 32630
Biol. unit: Hexamer (from PDB file)
Resolution:
1.77Å     R-factor:   0.163     R-free:   0.188
Authors: M.G.Grutter
Key ref: O.D.Ekici et al. (2006). Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10. J Med Chem, 49, 5728-5749. PubMed id: 16970398 DOI: 10.1021/jm0601405
Date:
14-Sep-05     Release date:   20-Sep-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P42574  (CASP3_HUMAN) -  Caspase-3 from Homo sapiens
Seq:
Struc:
277 a.a.
147 a.a.
Protein chain
Pfam   ArchSchema ?
P42574  (CASP3_HUMAN) -  Caspase-3 from Homo sapiens
Seq:
Struc:
277 a.a.
103 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chains A, B: E.C.3.4.22.56  - caspase-3.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1021/jm0601405 J Med Chem 49:5728-5749 (2006)
PubMed id: 16970398  
 
 
Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
O.D.Ekici, Z.Z.Li, A.J.Campbell, K.E.James, J.L.Asgian, J.Mikolajczyk, G.S.Salvesen, R.Ganesan, S.Jelakovic, M.G.Grütter, J.C.Powers.
 
  ABSTRACT  
 
Aza-peptide Michael acceptors are a novel class of inhibitors that are potent and specific for caspases-2, -3, -6, -7, -8, -9, and -10. The second-order rate constants are in the order of 10(6) M(-1) s(-1). The aza-peptide Michael acceptor inhibitor 18t (Cbz-Asp-Glu-Val-AAsp-trans-CH=CH-CON(CH(2)-1-Naphth)(2) is the most potent compound and it inhibits caspase-3 with a k(2) value of 5620000 M(-1) s(-1). The inhibitor 18t is 13700, 190, 6.4, 594, 37500, and 173-fold more selective for caspase-3 over caspases-2, -6, -7, -8, -9, and -10, respectively. Aza-peptide Michael acceptors designed with caspase specific sequences are selective and do not show any cross reactivity with clan CA cysteine proteases such as papain, cathepsin B, and calpains. High-resolution crystal structures of caspase-3 and caspase-8 in complex with aza-peptide Michael acceptor inhibitors demonstrate the nucleophilic attack on C2 and provide insight into the selectivity and potency of the inhibitors with respect to the P1' moiety.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
21095569 M.J.Leyva, F.Degiacomo, L.S.Kaltenbach, J.Holcomb, N.Zhang, J.Gafni, H.Park, D.C.Lo, G.S.Salvesen, L.M.Ellerby, and J.A.Ellman (2010).
Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models.
  Chem Biol, 17, 1189-1200.  
20112330 S.Amslinger (2010).
The tunable functionality of alpha,beta-unsaturated carbonyl compounds enables their differential application in biological systems.
  ChemMedChem, 5, 351-356.  
19077216 H.J.Kang, Y.M.Lee, Y.J.Jeong, K.Park, M.Jang, S.G.Park, K.H.Bae, M.Kim, and S.J.Chung (2008).
Large-scale preparation of active caspase-3 in E. coli by designing its thrombin-activatable precursors.
  BMC Biotechnol, 8, 92.  
17181171 K.S.Babu, X.C.Li, M.R.Jacob, Q.Zhang, S.I.Khan, D.Ferreira, and A.M.Clark (2006).
Synthesis, antifungal activity, and structure-activity relationships of coruscanone A analogues.
  J Med Chem, 49, 7877-7886.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer